​

BeOne Medicines Ownership | Who Owns BeOne Medicines?

OverviewForecastRevenueFinancialsChartTranscripts

BeOne Medicines Ownership Summary

BeOne Medicines is owned by 31.54% institutional investors, 17.29% insiders, and 51.17% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 8.07% of ONC shares. Capital Group New Perspective Comp is the top mutual fund, with 2.57% of its assets in BeOne Medicines shares.

ONC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBeOne Medicines31.54%17.29%51.17%
SectorHealthcare Stocks 35.78%11.87%52.36%
IndustryBiotech Stocks 36.05%11.82%52.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp8.80M8.07%$2.61B
Primecap management co/ca/4.98M4.56%$1.48B
Capital investors4.16M3.81%$1.23B
Fmr3.69M3.39%$1.10B
Thomas j. herzfeld advisors2.05M1.86%$29.00M
Capital world investors1.62M1.49%$481.89M
Hhlr advisors1.03M0.95%$307.16M
Citadel advisors1.03M0.95%$306.56M
Temasek (private)862.64K0.79%$256.18M
Blackrock funding, inc. /de657.50K0.60%$195.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Hhlr advisors1.03M18.36%$307.16M
Baker bros. advisors lp8.80M15.00%$2.61B
Thomas j. herzfeld advisors2.05M9.81%$29.00M
Patient square capital lp80.54K4.24%$23.92M
Healthinvest partners ab41.72K3.92%$12.14M
Nan fung group15.72K3.85%$4.67M
Siren465.00K3.83%$138.09M
Jgp global gestao de recursos ltda.1.71K2.19%$508.12K
Primecap management co/ca/4.98M1.16%$1.48B
Slow capital28.49K1.10%$8.46M

Top Buyers

HolderShares% AssetsChange
Thomas j. herzfeld advisors2.05M9.81%2.05M
Capital world investors1.62M0.07%1.62M
Citadel advisors1.03M0.05%498.78K
Ubs group415.33K0.02%263.24K
Millennium management204.85K0.03%173.40K

Top Sellers

HolderShares% AssetsChange
Capital investors4.16M0.29%-955.14K
Price t rowe associates inc /md/539.77K0.02%-832.91K
Fmr3.69M0.06%-299.02K
Jain global1.67K0.00%-95.67K
Qube research---94.85K

New Positions

HolderShares% AssetsChangeValue
Thomas j. herzfeld advisors2.05M9.81%2.05M$29.00M
Capital world investors1.62M0.07%1.62M$481.89M
North ground capital135.32K0.95%135.32K$1.91M
Arete wealth advisors99.33K0.09%99.33K$1.40M
Resources investment advisors, llc.97.13K0.01%97.13K$1.37M

Sold Out

HolderChange
Cullen/frost bankers-1.00
Hm payson-2.00
Ancora advisors-4.00
Elyxium wealth-6.00
Reyes financial architecture-8.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026290-19.22%34,397,333-32.01%311.50%136-41.38%9734.72%
Dec 31, 2025154-44.80%12,358,898-62.55%111.25%87-43.87%40-48.72%
Sep 30, 202527910.71%32,997,831-4.21%292.97%15530.25%78-8.24%
Jun 30, 2025252-8.70%34,449,266-19.00%312.01%119-21.71%858.97%
Mar 31, 202527616.95%42,530,835-2.67%392.35%15236.94%78-1.27%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Capital Group New Perspective Comp2.66M2.57%291.19K
American Funds New Perspective A2.66M2.57%291.19K
Vanguard PRIMECAP Inv2.32M2.24%-1.30K
Vanguard Capital Opportunity Inv1.17M1.13%-1.60K
NT Emerg Markets Index Fund - NL865.27K0.83%-18.20K
Fidelity Growth Compy Commingled Pl S827.59K0.74%564.00
American Funds EUPAC A730.39K0.70%133.28K
Capital Group EUPAC Composite730.39K0.70%133.28K
American Funds New World A662.55K0.64%94.26K
Capital Group New Geography Equity Comp662.55K0.64%94.26K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 23, 2026Wu Xiaobin President and COOSell$356.93K
Jun 23, 2026OYLER JOHN Chief Executive OfficerSell$353.61K
Jun 23, 2026OYLER JOHN Chief Executive OfficerSell$88.03K
Jun 23, 2026OYLER JOHN Chief Executive OfficerSell$491.95K
Jun 23, 2026Wang Lai President, Global Head of R&DSell$295.55K

Insider Transactions Trends

DateBuySell
2026 Q2-40
2026 Q1-4
2025 Q4-47
2025 Q3-42
2025 Q2-38

ONC Ownership FAQ

Who Owns BeOne Medicines?

BeOne Medicines shareholders are primarily institutional investors at 31.54%, followed by 17.29% insiders and 51.17% retail investors. The average institutional ownership in BeOne Medicines's industry, Biotech Stocks , is 36.05%, which BeOne Medicines falls below.

Who owns the most shares of BeOne Medicines?

BeOne Medicines’s largest shareholders are Baker bros. advisors lp (8.8M shares, 8.07%), Primecap management co/ca/ (4.98M shares, 4.56%), and Capital investors (4.16M shares, 3.81%). Together, they hold 16.44% of BeOne Medicines’s total shares outstanding.

Does Blackrock own BeOne Medicines?

BlackRock is not among the top 10 institutional shareholders of BeOne Medicines.

Who is BeOne Medicines’s biggest shareholder by percentage of total assets invested?

Hhlr advisors is BeOne Medicines’s biggest shareholder by percentage of total assets invested, with 18.36% of its assets in 1.03M BeOne Medicines shares, valued at 307.16M$.

Who is the top mutual fund holder of BeOne Medicines shares?

Capital Group New Perspective Comp is the top mutual fund holder of BeOne Medicines shares, with 2.57% of its total shares outstanding invested in 2.66M BeOne Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools